nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—Cytochrome P450 3A4 Inhibitors—Pazopanib—kidney cancer	0.333	0.5	CiPCiCtD
Efavirenz—Cytochrome P450 3A4 Inhibitors—Everolimus—kidney cancer	0.333	0.5	CiPCiCtD
Efavirenz—CYP2D6—Temsirolimus—kidney cancer	0.0211	0.0991	CbGbCtD
Efavirenz—CYP3A4—Everolimus—kidney cancer	0.0198	0.0933	CbGbCtD
Efavirenz—CYP1A2—Pazopanib—kidney cancer	0.0134	0.0632	CbGbCtD
Efavirenz—CYP3A4—Temsirolimus—kidney cancer	0.0134	0.063	CbGbCtD
Efavirenz—CYP2B6—Sorafenib—kidney cancer	0.0133	0.0625	CbGbCtD
Efavirenz—CYP2C9—Capecitabine—kidney cancer	0.0126	0.0594	CbGbCtD
Efavirenz—CYP2D6—Pazopanib—kidney cancer	0.0111	0.0521	CbGbCtD
Efavirenz—CYP1A2—Erlotinib—kidney cancer	0.00959	0.0451	CbGbCtD
Efavirenz—CYP2C19—Sorafenib—kidney cancer	0.00845	0.0397	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—kidney cancer	0.00807	0.0379	CbGbCtD
Efavirenz—CYP2C9—Paclitaxel—kidney cancer	0.00791	0.0372	CbGbCtD
Efavirenz—CYP2D6—Erlotinib—kidney cancer	0.0079	0.0371	CbGbCtD
Efavirenz—CYP1A2—Sorafenib—kidney cancer	0.0078	0.0367	CbGbCtD
Efavirenz—CYP3A4—Pazopanib—kidney cancer	0.00704	0.0331	CbGbCtD
Efavirenz—CYP2C9—Sorafenib—kidney cancer	0.00703	0.033	CbGbCtD
Efavirenz—CYP2D6—Sorafenib—kidney cancer	0.00643	0.0302	CbGbCtD
Efavirenz—CYP2D6—Vinblastine—kidney cancer	0.00634	0.0298	CbGbCtD
Efavirenz—CYP3A4—Erlotinib—kidney cancer	0.00502	0.0236	CbGbCtD
Efavirenz—CYP3A4—Paclitaxel—kidney cancer	0.0046	0.0216	CbGbCtD
Efavirenz—CYP3A4—Sorafenib—kidney cancer	0.00409	0.0192	CbGbCtD
Efavirenz—CYP3A4—Vinblastine—kidney cancer	0.00403	0.019	CbGbCtD
Efavirenz—CYP3A4—Vincristine—kidney cancer	0.00397	0.0186	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—kidney cancer	0.0039	0.0183	CbGbCtD
Efavirenz—CYP3A4—Sunitinib—kidney cancer	0.00331	0.0156	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—kidney cancer	0.00248	0.0117	CbGbCtD
Efavirenz—CYP2C19—urine—kidney cancer	0.00105	0.189	CbGeAlD
Efavirenz—CYP1A2—urine—kidney cancer	0.000861	0.154	CbGeAlD
Efavirenz—CYP2C9—urine—kidney cancer	0.000818	0.147	CbGeAlD
Efavirenz—CYP3A4—urine—kidney cancer	0.000623	0.112	CbGeAlD
Efavirenz—CYP2D6—urine—kidney cancer	0.000614	0.11	CbGeAlD
Efavirenz—CYP2B6—nephron tubule—kidney cancer	0.000222	0.0398	CbGeAlD
Efavirenz—CYP1A2—renal system—kidney cancer	0.000211	0.0378	CbGeAlD
Efavirenz—CYP2B6—renal system—kidney cancer	0.000202	0.0362	CbGeAlD
Efavirenz—CYP2B6—kidney—kidney cancer	0.000195	0.035	CbGeAlD
Efavirenz—CYP2B6—gonad—kidney cancer	0.000181	0.0325	CbGeAlD
Efavirenz—CYP3A4—renal system—kidney cancer	0.000153	0.0274	CbGeAlD
Efavirenz—CYP2D6—renal system—kidney cancer	0.00015	0.0269	CbGeAlD
Efavirenz—CYP3A4—kidney—kidney cancer	0.000147	0.0264	CbGeAlD
Efavirenz—CYP2D6—kidney—kidney cancer	0.000145	0.026	CbGeAlD
Efavirenz—Myalgia—Paclitaxel—kidney cancer	4.05e-05	0.000369	CcSEcCtD
Efavirenz—Mediastinal disorder—Capecitabine—kidney cancer	4.04e-05	0.000368	CcSEcCtD
Efavirenz—Anxiety—Paclitaxel—kidney cancer	4.03e-05	0.000368	CcSEcCtD
Efavirenz—Decreased appetite—Gemcitabine—kidney cancer	4.03e-05	0.000367	CcSEcCtD
Efavirenz—Hypersensitivity—Dactinomycin—kidney cancer	4.03e-05	0.000367	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	4.02e-05	0.000367	CcSEcCtD
Efavirenz—Arrhythmia—Capecitabine—kidney cancer	4e-05	0.000365	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Gemcitabine—kidney cancer	4e-05	0.000365	CcSEcCtD
Efavirenz—Discomfort—Paclitaxel—kidney cancer	4e-05	0.000365	CcSEcCtD
Efavirenz—Fatigue—Gemcitabine—kidney cancer	4e-05	0.000364	CcSEcCtD
Efavirenz—Gastrointestinal pain—Vincristine—kidney cancer	4e-05	0.000364	CcSEcCtD
Efavirenz—Dizziness—Sorafenib—kidney cancer	3.97e-05	0.000362	CcSEcCtD
Efavirenz—Pain—Gemcitabine—kidney cancer	3.96e-05	0.000361	CcSEcCtD
Efavirenz—Constipation—Gemcitabine—kidney cancer	3.96e-05	0.000361	CcSEcCtD
Efavirenz—Nausea—Erlotinib—kidney cancer	3.96e-05	0.000361	CcSEcCtD
Efavirenz—Alopecia—Capecitabine—kidney cancer	3.96e-05	0.000361	CcSEcCtD
Efavirenz—Dry mouth—Paclitaxel—kidney cancer	3.96e-05	0.000361	CcSEcCtD
Efavirenz—Mood swings—Doxorubicin—kidney cancer	3.96e-05	0.000361	CcSEcCtD
Efavirenz—Diarrhoea—Sunitinib—kidney cancer	3.95e-05	0.00036	CcSEcCtD
Efavirenz—Ataxia—Doxorubicin—kidney cancer	3.93e-05	0.000358	CcSEcCtD
Efavirenz—Asthenia—Dactinomycin—kidney cancer	3.92e-05	0.000358	CcSEcCtD
Efavirenz—Confusional state—Paclitaxel—kidney cancer	3.91e-05	0.000357	CcSEcCtD
Efavirenz—Blood creatinine increased—Doxorubicin—kidney cancer	3.91e-05	0.000357	CcSEcCtD
Efavirenz—Erythema—Capecitabine—kidney cancer	3.9e-05	0.000356	CcSEcCtD
Efavirenz—Malnutrition—Capecitabine—kidney cancer	3.9e-05	0.000356	CcSEcCtD
Efavirenz—Body temperature increased—Vincristine—kidney cancer	3.86e-05	0.000352	CcSEcCtD
Efavirenz—Abdominal pain—Vincristine—kidney cancer	3.86e-05	0.000352	CcSEcCtD
Efavirenz—Flatulence—Capecitabine—kidney cancer	3.84e-05	0.000351	CcSEcCtD
Efavirenz—Dysgeusia—Capecitabine—kidney cancer	3.82e-05	0.000348	CcSEcCtD
Efavirenz—Dizziness—Sunitinib—kidney cancer	3.82e-05	0.000348	CcSEcCtD
Efavirenz—Feeling abnormal—Gemcitabine—kidney cancer	3.82e-05	0.000348	CcSEcCtD
Efavirenz—Shock—Paclitaxel—kidney cancer	3.82e-05	0.000348	CcSEcCtD
Efavirenz—Vomiting—Sorafenib—kidney cancer	3.82e-05	0.000348	CcSEcCtD
Efavirenz—Nervous system disorder—Paclitaxel—kidney cancer	3.81e-05	0.000347	CcSEcCtD
Efavirenz—Hypokalaemia—Doxorubicin—kidney cancer	3.8e-05	0.000347	CcSEcCtD
Efavirenz—Thrombocytopenia—Paclitaxel—kidney cancer	3.8e-05	0.000346	CcSEcCtD
Efavirenz—Tachycardia—Paclitaxel—kidney cancer	3.79e-05	0.000345	CcSEcCtD
Efavirenz—Rash—Sorafenib—kidney cancer	3.78e-05	0.000345	CcSEcCtD
Efavirenz—Dermatitis—Sorafenib—kidney cancer	3.78e-05	0.000345	CcSEcCtD
Efavirenz—Back pain—Capecitabine—kidney cancer	3.77e-05	0.000344	CcSEcCtD
Efavirenz—Breast disorder—Doxorubicin—kidney cancer	3.77e-05	0.000344	CcSEcCtD
Efavirenz—Skin disorder—Paclitaxel—kidney cancer	3.77e-05	0.000344	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	3.76e-05	0.000343	CcSEcCtD
Efavirenz—Headache—Sorafenib—kidney cancer	3.76e-05	0.000343	CcSEcCtD
Efavirenz—Hyperhidrosis—Paclitaxel—kidney cancer	3.75e-05	0.000342	CcSEcCtD
Efavirenz—Diarrhoea—Dactinomycin—kidney cancer	3.74e-05	0.000341	CcSEcCtD
Efavirenz—Nasopharyngitis—Doxorubicin—kidney cancer	3.73e-05	0.000341	CcSEcCtD
Efavirenz—Anorexia—Paclitaxel—kidney cancer	3.7e-05	0.000337	CcSEcCtD
Efavirenz—Muscular weakness—Doxorubicin—kidney cancer	3.68e-05	0.000336	CcSEcCtD
Efavirenz—Vision blurred—Capecitabine—kidney cancer	3.68e-05	0.000335	CcSEcCtD
Efavirenz—Vomiting—Sunitinib—kidney cancer	3.67e-05	0.000335	CcSEcCtD
Efavirenz—Body temperature increased—Gemcitabine—kidney cancer	3.66e-05	0.000334	CcSEcCtD
Efavirenz—Tremor—Capecitabine—kidney cancer	3.66e-05	0.000333	CcSEcCtD
Efavirenz—Rash—Sunitinib—kidney cancer	3.64e-05	0.000332	CcSEcCtD
Efavirenz—Dermatitis—Sunitinib—kidney cancer	3.64e-05	0.000332	CcSEcCtD
Efavirenz—Abdominal distension—Doxorubicin—kidney cancer	3.63e-05	0.000331	CcSEcCtD
Efavirenz—Ill-defined disorder—Capecitabine—kidney cancer	3.62e-05	0.00033	CcSEcCtD
Efavirenz—Headache—Sunitinib—kidney cancer	3.62e-05	0.00033	CcSEcCtD
Efavirenz—Asthma—Doxorubicin—kidney cancer	3.61e-05	0.000329	CcSEcCtD
Efavirenz—Anaemia—Capecitabine—kidney cancer	3.61e-05	0.000329	CcSEcCtD
Efavirenz—Hypersensitivity—Vincristine—kidney cancer	3.6e-05	0.000328	CcSEcCtD
Efavirenz—Nausea—Sorafenib—kidney cancer	3.57e-05	0.000325	CcSEcCtD
Efavirenz—Pancreatitis—Doxorubicin—kidney cancer	3.54e-05	0.000323	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.54e-05	0.000322	CcSEcCtD
Efavirenz—Malaise—Capecitabine—kidney cancer	3.52e-05	0.000321	CcSEcCtD
Efavirenz—Insomnia—Paclitaxel—kidney cancer	3.51e-05	0.00032	CcSEcCtD
Efavirenz—Vertigo—Capecitabine—kidney cancer	3.51e-05	0.00032	CcSEcCtD
Efavirenz—Asthenia—Vincristine—kidney cancer	3.51e-05	0.00032	CcSEcCtD
Efavirenz—Syncope—Capecitabine—kidney cancer	3.5e-05	0.000319	CcSEcCtD
Efavirenz—Paraesthesia—Paclitaxel—kidney cancer	3.48e-05	0.000318	CcSEcCtD
Efavirenz—Vomiting—Dactinomycin—kidney cancer	3.48e-05	0.000317	CcSEcCtD
Efavirenz—Dyspnoea—Paclitaxel—kidney cancer	3.46e-05	0.000315	CcSEcCtD
Efavirenz—Somnolence—Paclitaxel—kidney cancer	3.45e-05	0.000315	CcSEcCtD
Efavirenz—Palpitations—Capecitabine—kidney cancer	3.45e-05	0.000314	CcSEcCtD
Efavirenz—Rash—Dactinomycin—kidney cancer	3.45e-05	0.000314	CcSEcCtD
Efavirenz—Nausea—Sunitinib—kidney cancer	3.43e-05	0.000313	CcSEcCtD
Efavirenz—Loss of consciousness—Capecitabine—kidney cancer	3.43e-05	0.000313	CcSEcCtD
Efavirenz—Pancytopenia—Doxorubicin—kidney cancer	3.43e-05	0.000313	CcSEcCtD
Efavirenz—Dyspepsia—Paclitaxel—kidney cancer	3.42e-05	0.000311	CcSEcCtD
Efavirenz—Cough—Capecitabine—kidney cancer	3.4e-05	0.00031	CcSEcCtD
Efavirenz—Decreased appetite—Paclitaxel—kidney cancer	3.37e-05	0.000308	CcSEcCtD
Efavirenz—Hypertension—Capecitabine—kidney cancer	3.37e-05	0.000307	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.35e-05	0.000306	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.35e-05	0.000305	CcSEcCtD
Efavirenz—Fatigue—Paclitaxel—kidney cancer	3.35e-05	0.000305	CcSEcCtD
Efavirenz—Diarrhoea—Vincristine—kidney cancer	3.34e-05	0.000305	CcSEcCtD
Efavirenz—Asthenia—Gemcitabine—kidney cancer	3.33e-05	0.000303	CcSEcCtD
Efavirenz—Arthralgia—Capecitabine—kidney cancer	3.32e-05	0.000303	CcSEcCtD
Efavirenz—Chest pain—Capecitabine—kidney cancer	3.32e-05	0.000303	CcSEcCtD
Efavirenz—Myalgia—Capecitabine—kidney cancer	3.32e-05	0.000303	CcSEcCtD
Efavirenz—Constipation—Paclitaxel—kidney cancer	3.32e-05	0.000303	CcSEcCtD
Efavirenz—Pain—Paclitaxel—kidney cancer	3.32e-05	0.000303	CcSEcCtD
Efavirenz—Anxiety—Capecitabine—kidney cancer	3.31e-05	0.000302	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.3e-05	0.000301	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—kidney cancer	3.29e-05	0.0003	CcSEcCtD
Efavirenz—Discomfort—Capecitabine—kidney cancer	3.28e-05	0.000299	CcSEcCtD
Efavirenz—Pruritus—Gemcitabine—kidney cancer	3.28e-05	0.000299	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—kidney cancer	3.26e-05	0.000297	CcSEcCtD
Efavirenz—Dry mouth—Capecitabine—kidney cancer	3.25e-05	0.000296	CcSEcCtD
Efavirenz—Nausea—Dactinomycin—kidney cancer	3.25e-05	0.000296	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—kidney cancer	3.24e-05	0.000295	CcSEcCtD
Efavirenz—Dizziness—Vincristine—kidney cancer	3.23e-05	0.000295	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—kidney cancer	3.22e-05	0.000293	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—kidney cancer	3.22e-05	0.000293	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—kidney cancer	3.22e-05	0.000293	CcSEcCtD
Efavirenz—Confusional state—Capecitabine—kidney cancer	3.21e-05	0.000293	CcSEcCtD
Efavirenz—Feeling abnormal—Paclitaxel—kidney cancer	3.2e-05	0.000292	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.19e-05	0.000291	CcSEcCtD
Efavirenz—Gastrointestinal pain—Paclitaxel—kidney cancer	3.17e-05	0.000289	CcSEcCtD
Efavirenz—Diarrhoea—Gemcitabine—kidney cancer	3.17e-05	0.000289	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—kidney cancer	3.16e-05	0.000288	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—kidney cancer	3.15e-05	0.000288	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—kidney cancer	3.14e-05	0.000286	CcSEcCtD
Efavirenz—Shock—Capecitabine—kidney cancer	3.13e-05	0.000286	CcSEcCtD
Efavirenz—Nervous system disorder—Capecitabine—kidney cancer	3.12e-05	0.000285	CcSEcCtD
Efavirenz—Thrombocytopenia—Capecitabine—kidney cancer	3.12e-05	0.000284	CcSEcCtD
Efavirenz—Tachycardia—Capecitabine—kidney cancer	3.11e-05	0.000283	CcSEcCtD
Efavirenz—Vomiting—Vincristine—kidney cancer	3.11e-05	0.000283	CcSEcCtD
Efavirenz—Skin disorder—Capecitabine—kidney cancer	3.09e-05	0.000282	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—kidney cancer	3.09e-05	0.000281	CcSEcCtD
Efavirenz—Urticaria—Paclitaxel—kidney cancer	3.08e-05	0.000281	CcSEcCtD
Efavirenz—Rash—Vincristine—kidney cancer	3.08e-05	0.000281	CcSEcCtD
Efavirenz—Hyperhidrosis—Capecitabine—kidney cancer	3.08e-05	0.000281	CcSEcCtD
Efavirenz—Dermatitis—Vincristine—kidney cancer	3.08e-05	0.000281	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—kidney cancer	3.07e-05	0.00028	CcSEcCtD
Efavirenz—Abdominal pain—Paclitaxel—kidney cancer	3.07e-05	0.00028	CcSEcCtD
Efavirenz—Body temperature increased—Paclitaxel—kidney cancer	3.07e-05	0.00028	CcSEcCtD
Efavirenz—Headache—Vincristine—kidney cancer	3.06e-05	0.000279	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—kidney cancer	3.04e-05	0.000278	CcSEcCtD
Efavirenz—Anorexia—Capecitabine—kidney cancer	3.04e-05	0.000277	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—kidney cancer	3.02e-05	0.000275	CcSEcCtD
Efavirenz—Vomiting—Gemcitabine—kidney cancer	2.95e-05	0.000269	CcSEcCtD
Efavirenz—Rash—Gemcitabine—kidney cancer	2.92e-05	0.000266	CcSEcCtD
Efavirenz—Dermatitis—Gemcitabine—kidney cancer	2.92e-05	0.000266	CcSEcCtD
Efavirenz—Headache—Gemcitabine—kidney cancer	2.9e-05	0.000265	CcSEcCtD
Efavirenz—Nausea—Vincristine—kidney cancer	2.9e-05	0.000265	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.9e-05	0.000265	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—kidney cancer	2.9e-05	0.000264	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—kidney cancer	2.89e-05	0.000263	CcSEcCtD
Efavirenz—Insomnia—Capecitabine—kidney cancer	2.88e-05	0.000263	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—kidney cancer	2.87e-05	0.000262	CcSEcCtD
Efavirenz—Paraesthesia—Capecitabine—kidney cancer	2.86e-05	0.000261	CcSEcCtD
Efavirenz—Hypersensitivity—Paclitaxel—kidney cancer	2.86e-05	0.000261	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—kidney cancer	2.85e-05	0.00026	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—kidney cancer	2.85e-05	0.00026	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—kidney cancer	2.84e-05	0.000259	CcSEcCtD
Efavirenz—Dyspnoea—Capecitabine—kidney cancer	2.84e-05	0.000259	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—kidney cancer	2.83e-05	0.000258	CcSEcCtD
Efavirenz—Dyspepsia—Capecitabine—kidney cancer	2.8e-05	0.000256	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—kidney cancer	2.78e-05	0.000254	CcSEcCtD
Efavirenz—Asthenia—Paclitaxel—kidney cancer	2.78e-05	0.000254	CcSEcCtD
Efavirenz—Decreased appetite—Capecitabine—kidney cancer	2.77e-05	0.000252	CcSEcCtD
Efavirenz—Nausea—Gemcitabine—kidney cancer	2.75e-05	0.000251	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Capecitabine—kidney cancer	2.75e-05	0.000251	CcSEcCtD
Efavirenz—Fatigue—Capecitabine—kidney cancer	2.75e-05	0.00025	CcSEcCtD
Efavirenz—Pruritus—Paclitaxel—kidney cancer	2.75e-05	0.00025	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—kidney cancer	2.73e-05	0.000249	CcSEcCtD
Efavirenz—Pain—Capecitabine—kidney cancer	2.72e-05	0.000248	CcSEcCtD
Efavirenz—Constipation—Capecitabine—kidney cancer	2.72e-05	0.000248	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—kidney cancer	2.7e-05	0.000246	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—kidney cancer	2.69e-05	0.000246	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—kidney cancer	2.68e-05	0.000244	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—kidney cancer	2.68e-05	0.000244	CcSEcCtD
Efavirenz—Diarrhoea—Paclitaxel—kidney cancer	2.66e-05	0.000242	CcSEcCtD
Efavirenz—Feeling abnormal—Capecitabine—kidney cancer	2.62e-05	0.000239	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—kidney cancer	2.62e-05	0.000239	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—kidney cancer	2.61e-05	0.000238	CcSEcCtD
Efavirenz—Gastrointestinal pain—Capecitabine—kidney cancer	2.6e-05	0.000237	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—kidney cancer	2.6e-05	0.000237	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—kidney cancer	2.58e-05	0.000235	CcSEcCtD
Efavirenz—Dizziness—Paclitaxel—kidney cancer	2.57e-05	0.000234	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—kidney cancer	2.55e-05	0.000233	CcSEcCtD
Efavirenz—Urticaria—Capecitabine—kidney cancer	2.53e-05	0.000231	CcSEcCtD
Efavirenz—Body temperature increased—Capecitabine—kidney cancer	2.52e-05	0.00023	CcSEcCtD
Efavirenz—Abdominal pain—Capecitabine—kidney cancer	2.52e-05	0.00023	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—kidney cancer	2.52e-05	0.000229	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—kidney cancer	2.52e-05	0.000229	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—kidney cancer	2.48e-05	0.000226	CcSEcCtD
Efavirenz—Tension—Doxorubicin—kidney cancer	2.47e-05	0.000225	CcSEcCtD
Efavirenz—Vomiting—Paclitaxel—kidney cancer	2.47e-05	0.000225	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—kidney cancer	2.46e-05	0.000225	CcSEcCtD
Efavirenz—Rash—Paclitaxel—kidney cancer	2.45e-05	0.000223	CcSEcCtD
Efavirenz—Dermatitis—Paclitaxel—kidney cancer	2.44e-05	0.000223	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—kidney cancer	2.44e-05	0.000223	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—kidney cancer	2.43e-05	0.000222	CcSEcCtD
Efavirenz—Headache—Paclitaxel—kidney cancer	2.43e-05	0.000222	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—kidney cancer	2.37e-05	0.000216	CcSEcCtD
Efavirenz—Hypersensitivity—Capecitabine—kidney cancer	2.35e-05	0.000214	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—kidney cancer	2.33e-05	0.000213	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—kidney cancer	2.32e-05	0.000212	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—kidney cancer	2.31e-05	0.000211	CcSEcCtD
Efavirenz—Nausea—Paclitaxel—kidney cancer	2.3e-05	0.00021	CcSEcCtD
Efavirenz—Asthenia—Capecitabine—kidney cancer	2.28e-05	0.000208	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—kidney cancer	2.27e-05	0.000207	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—kidney cancer	2.26e-05	0.000206	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—kidney cancer	2.26e-05	0.000206	CcSEcCtD
Efavirenz—Pruritus—Capecitabine—kidney cancer	2.25e-05	0.000205	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—kidney cancer	2.22e-05	0.000203	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—kidney cancer	2.21e-05	0.000202	CcSEcCtD
Efavirenz—Cough—Doxorubicin—kidney cancer	2.19e-05	0.0002	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—kidney cancer	2.18e-05	0.000199	CcSEcCtD
Efavirenz—Diarrhoea—Capecitabine—kidney cancer	2.18e-05	0.000199	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—kidney cancer	2.17e-05	0.000198	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—kidney cancer	2.14e-05	0.000195	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—kidney cancer	2.14e-05	0.000195	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—kidney cancer	2.14e-05	0.000195	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—kidney cancer	2.13e-05	0.000195	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.13e-05	0.000194	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—kidney cancer	2.12e-05	0.000193	CcSEcCtD
Efavirenz—Dizziness—Capecitabine—kidney cancer	2.11e-05	0.000192	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—kidney cancer	2.09e-05	0.000191	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—kidney cancer	2.07e-05	0.000189	CcSEcCtD
Efavirenz—Vomiting—Capecitabine—kidney cancer	2.02e-05	0.000185	CcSEcCtD
Efavirenz—Shock—Doxorubicin—kidney cancer	2.02e-05	0.000184	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—kidney cancer	2.01e-05	0.000184	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—kidney cancer	2.01e-05	0.000183	CcSEcCtD
Efavirenz—Rash—Capecitabine—kidney cancer	2.01e-05	0.000183	CcSEcCtD
Efavirenz—Dermatitis—Capecitabine—kidney cancer	2.01e-05	0.000183	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—kidney cancer	2e-05	0.000183	CcSEcCtD
Efavirenz—Headache—Capecitabine—kidney cancer	1.99e-05	0.000182	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—kidney cancer	1.99e-05	0.000182	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—kidney cancer	1.98e-05	0.000181	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—kidney cancer	1.96e-05	0.000178	CcSEcCtD
Efavirenz—Nausea—Capecitabine—kidney cancer	1.89e-05	0.000172	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.87e-05	0.000171	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—kidney cancer	1.86e-05	0.000169	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—kidney cancer	1.84e-05	0.000168	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—kidney cancer	1.83e-05	0.000167	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—kidney cancer	1.82e-05	0.000166	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—kidney cancer	1.81e-05	0.000165	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—kidney cancer	1.78e-05	0.000163	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.77e-05	0.000162	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—kidney cancer	1.77e-05	0.000161	CcSEcCtD
Efavirenz—Pain—Doxorubicin—kidney cancer	1.76e-05	0.00016	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—kidney cancer	1.76e-05	0.00016	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—kidney cancer	1.69e-05	0.000154	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—kidney cancer	1.68e-05	0.000153	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—kidney cancer	1.63e-05	0.000149	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—kidney cancer	1.62e-05	0.000148	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—kidney cancer	1.62e-05	0.000148	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—kidney cancer	1.51e-05	0.000138	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—kidney cancer	1.47e-05	0.000134	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—kidney cancer	1.45e-05	0.000132	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—kidney cancer	1.4e-05	0.000128	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—kidney cancer	1.36e-05	0.000124	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—kidney cancer	1.31e-05	0.000119	CcSEcCtD
Efavirenz—Rash—Doxorubicin—kidney cancer	1.29e-05	0.000118	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—kidney cancer	1.29e-05	0.000118	CcSEcCtD
Efavirenz—Headache—Doxorubicin—kidney cancer	1.29e-05	0.000117	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—kidney cancer	1.22e-05	0.000111	CcSEcCtD
Efavirenz—CYP1A2—Biological oxidations—GSTP1—kidney cancer	7.66e-06	0.00123	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	7.63e-06	0.00123	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	7.56e-06	0.00121	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ACY1—kidney cancer	7.53e-06	0.00121	CbGpPWpGaD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.23e-06	0.00116	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—GSTM1—kidney cancer	7.04e-06	0.00113	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	6.94e-06	0.00112	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ACY1—kidney cancer	6.93e-06	0.00111	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GLIPR1—kidney cancer	6.91e-06	0.00111	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPAT—kidney cancer	6.91e-06	0.00111	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ACY1—kidney cancer	6.87e-06	0.0011	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	6.67e-06	0.00107	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	6.58e-06	0.00106	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.42e-06	0.00103	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APRT—kidney cancer	6.42e-06	0.00103	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—FH—kidney cancer	6.42e-06	0.00103	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PDHB—kidney cancer	6.41e-06	0.00103	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—POMC—kidney cancer	6.39e-06	0.00103	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GPC3—kidney cancer	6.04e-06	0.00097	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CCBL1—kidney cancer	6.02e-06	0.000967	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTP1—kidney cancer	5.91e-06	0.00095	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PDHB—kidney cancer	5.89e-06	0.000946	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CA2—kidney cancer	5.88e-06	0.000944	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—POMC—kidney cancer	5.87e-06	0.000943	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ACY1—kidney cancer	5.87e-06	0.000943	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.86e-06	0.000941	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PDHB—kidney cancer	5.84e-06	0.000938	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	5.83e-06	0.000936	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—POMC—kidney cancer	5.82e-06	0.000935	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALAD—kidney cancer	5.73e-06	0.00092	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ST3GAL2—kidney cancer	5.59e-06	0.000898	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CCBL1—kidney cancer	5.54e-06	0.00089	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CCBL1—kidney cancer	5.49e-06	0.000882	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALDH1A1—kidney cancer	5.46e-06	0.000877	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.45e-06	0.000875	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.43e-06	0.000873	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	5.36e-06	0.000861	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PGK1—kidney cancer	5.24e-06	0.000841	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SLC5A3—kidney cancer	5.24e-06	0.000841	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPAT—kidney cancer	5.22e-06	0.000839	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GLIPR1—kidney cancer	5.22e-06	0.000839	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.16e-06	0.000828	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	5.15e-06	0.000827	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—LDHB—kidney cancer	5.14e-06	0.000825	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.1e-06	0.00082	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	5.08e-06	0.000816	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.01e-06	0.000804	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PDHB—kidney cancer	4.99e-06	0.000802	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—POMC—kidney cancer	4.98e-06	0.000799	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.97e-06	0.000798	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—FH—kidney cancer	4.85e-06	0.00078	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APRT—kidney cancer	4.85e-06	0.00078	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPAT—kidney cancer	4.8e-06	0.000771	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GLIPR1—kidney cancer	4.8e-06	0.000771	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GLIPR1—kidney cancer	4.76e-06	0.000765	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPAT—kidney cancer	4.76e-06	0.000765	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.74e-06	0.000762	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.7e-06	0.000755	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CCBL1—kidney cancer	4.69e-06	0.000754	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.65e-06	0.000747	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GPC3—kidney cancer	4.56e-06	0.000733	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ACY1—kidney cancer	4.53e-06	0.000728	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APRT—kidney cancer	4.47e-06	0.000717	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—FH—kidney cancer	4.47e-06	0.000717	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CA9—kidney cancer	4.45e-06	0.000715	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CA2—kidney cancer	4.44e-06	0.000713	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—FH—kidney cancer	4.43e-06	0.000711	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APRT—kidney cancer	4.43e-06	0.000711	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALAD—kidney cancer	4.33e-06	0.000695	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.33e-06	0.000695	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.24e-06	0.000682	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ST3GAL2—kidney cancer	4.22e-06	0.000678	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GPC3—kidney cancer	4.2e-06	0.000674	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GPC3—kidney cancer	4.16e-06	0.000668	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALDH1A1—kidney cancer	4.13e-06	0.000663	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CA2—kidney cancer	4.08e-06	0.000656	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GLIPR1—kidney cancer	4.07e-06	0.000653	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPAT—kidney cancer	4.07e-06	0.000653	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CA2—kidney cancer	4.05e-06	0.00065	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.02e-06	0.000645	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALAD—kidney cancer	3.98e-06	0.000639	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.98e-06	0.000639	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PGK1—kidney cancer	3.96e-06	0.000636	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC5A3—kidney cancer	3.96e-06	0.000636	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALAD—kidney cancer	3.95e-06	0.000634	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ST3GAL2—kidney cancer	3.88e-06	0.000624	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—LDHB—kidney cancer	3.88e-06	0.000623	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PDHB—kidney cancer	3.85e-06	0.000619	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ST3GAL2—kidney cancer	3.85e-06	0.000618	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—POMC—kidney cancer	3.84e-06	0.000617	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALDH1A1—kidney cancer	3.8e-06	0.00061	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CRABP1—kidney cancer	3.79e-06	0.000608	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APRT—kidney cancer	3.78e-06	0.000608	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—FH—kidney cancer	3.78e-06	0.000608	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALDH1A1—kidney cancer	3.76e-06	0.000604	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.7e-06	0.000594	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PGK1—kidney cancer	3.64e-06	0.000585	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC5A3—kidney cancer	3.64e-06	0.000585	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CCBL1—kidney cancer	3.62e-06	0.000582	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PGK1—kidney cancer	3.61e-06	0.00058	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.61e-06	0.00058	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—LDHB—kidney cancer	3.57e-06	0.000573	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GPC3—kidney cancer	3.56e-06	0.000571	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LDHB—kidney cancer	3.54e-06	0.000568	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ITPR2—kidney cancer	3.52e-06	0.000565	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CA2—kidney cancer	3.46e-06	0.000556	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALAD—kidney cancer	3.37e-06	0.000541	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CA9—kidney cancer	3.36e-06	0.00054	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ST3GAL2—kidney cancer	3.29e-06	0.000529	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.29e-06	0.000528	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALDH1A1—kidney cancer	3.22e-06	0.000517	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ACHE—kidney cancer	3.21e-06	0.000516	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTT1—kidney cancer	3.21e-06	0.000516	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.14e-06	0.000504	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPAT—kidney cancer	3.14e-06	0.000504	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CA9—kidney cancer	3.09e-06	0.000497	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PGK1—kidney cancer	3.08e-06	0.000495	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC5A3—kidney cancer	3.08e-06	0.000495	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CA9—kidney cancer	3.07e-06	0.000493	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SCARB1—kidney cancer	3.04e-06	0.000488	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LDHB—kidney cancer	3.02e-06	0.000486	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS1—kidney cancer	3.01e-06	0.000483	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3e-06	0.000482	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PSMD7—kidney cancer	2.95e-06	0.000474	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—FH—kidney cancer	2.92e-06	0.000469	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APRT—kidney cancer	2.92e-06	0.000469	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CRABP1—kidney cancer	2.86e-06	0.00046	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—BCHE—kidney cancer	2.8e-06	0.000449	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SLC5A5—kidney cancer	2.76e-06	0.000444	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPC3—kidney cancer	2.74e-06	0.000441	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CA2—kidney cancer	2.67e-06	0.000429	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SLC2A1—kidney cancer	2.67e-06	0.000428	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ITPR2—kidney cancer	2.66e-06	0.000427	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CRABP1—kidney cancer	2.63e-06	0.000423	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CA9—kidney cancer	2.62e-06	0.000421	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CRABP1—kidney cancer	2.61e-06	0.000419	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALAD—kidney cancer	2.6e-06	0.000418	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.56e-06	0.000412	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.54e-06	0.000408	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.48e-06	0.000399	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.45e-06	0.000394	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ITPR2—kidney cancer	2.45e-06	0.000393	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ACHE—kidney cancer	2.43e-06	0.00039	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTT1—kidney cancer	2.43e-06	0.00039	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ITPR2—kidney cancer	2.43e-06	0.00039	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PGK1—kidney cancer	2.38e-06	0.000382	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.38e-06	0.000382	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LDHB—kidney cancer	2.33e-06	0.000375	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SCARB1—kidney cancer	2.3e-06	0.000369	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS1—kidney cancer	2.27e-06	0.000365	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.24e-06	0.000359	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTT1—kidney cancer	2.23e-06	0.000358	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ACHE—kidney cancer	2.23e-06	0.000358	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CRABP1—kidney cancer	2.23e-06	0.000358	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PSMD7—kidney cancer	2.23e-06	0.000358	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTP1—kidney cancer	2.22e-06	0.000357	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ACHE—kidney cancer	2.21e-06	0.000355	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTT1—kidney cancer	2.21e-06	0.000355	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—BCHE—kidney cancer	2.11e-06	0.000339	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SCARB1—kidney cancer	2.11e-06	0.000339	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ABCB1—kidney cancer	2.11e-06	0.000338	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SCARB1—kidney cancer	2.09e-06	0.000336	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS1—kidney cancer	2.09e-06	0.000336	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.09e-06	0.000335	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ITPR2—kidney cancer	2.07e-06	0.000333	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS1—kidney cancer	2.07e-06	0.000333	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PSMD7—kidney cancer	2.05e-06	0.000329	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—kidney cancer	2.04e-06	0.000328	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PSMD7—kidney cancer	2.03e-06	0.000326	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CA9—kidney cancer	2.02e-06	0.000325	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.02e-06	0.000324	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.96e-06	0.000314	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—BCHE—kidney cancer	1.94e-06	0.000312	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.94e-06	0.000311	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—BCHE—kidney cancer	1.93e-06	0.000309	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.92e-06	0.000308	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.91e-06	0.000307	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.9e-06	0.000306	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTT1—kidney cancer	1.89e-06	0.000304	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ACHE—kidney cancer	1.89e-06	0.000304	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.85e-06	0.000298	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.84e-06	0.000295	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SCARB1—kidney cancer	1.79e-06	0.000287	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.78e-06	0.000286	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS1—kidney cancer	1.77e-06	0.000284	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PSMD7—kidney cancer	1.74e-06	0.000279	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CRABP1—kidney cancer	1.72e-06	0.000276	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.71e-06	0.000274	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTP1—kidney cancer	1.68e-06	0.00027	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—BCHE—kidney cancer	1.65e-06	0.000264	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.63e-06	0.000261	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ITPR2—kidney cancer	1.6e-06	0.000257	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCB1—kidney cancer	1.59e-06	0.000256	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.57e-06	0.000252	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.56e-06	0.00025	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTP1—kidney cancer	1.55e-06	0.000248	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—kidney cancer	1.55e-06	0.000248	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTP1—kidney cancer	1.53e-06	0.000246	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.52e-06	0.000245	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.46e-06	0.000235	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCB1—kidney cancer	1.46e-06	0.000235	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTT1—kidney cancer	1.46e-06	0.000234	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ACHE—kidney cancer	1.46e-06	0.000234	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCB1—kidney cancer	1.45e-06	0.000233	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—POMC—kidney cancer	1.45e-06	0.000232	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—kidney cancer	1.42e-06	0.000228	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—kidney cancer	1.41e-06	0.000226	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SCARB1—kidney cancer	1.38e-06	0.000222	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS1—kidney cancer	1.37e-06	0.00022	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.35e-06	0.000216	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PSMD7—kidney cancer	1.34e-06	0.000215	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.34e-06	0.000214	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.33e-06	0.000213	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTP1—kidney cancer	1.31e-06	0.00021	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—BCHE—kidney cancer	1.27e-06	0.000204	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.26e-06	0.000202	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCB1—kidney cancer	1.24e-06	0.000199	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.21e-06	0.000195	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—kidney cancer	1.2e-06	0.000193	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.2e-06	0.000193	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—kidney cancer	1.15e-06	0.000185	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.14e-06	0.000183	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.1e-06	0.000176	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—POMC—kidney cancer	1.09e-06	0.000175	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTP1—kidney cancer	1.01e-06	0.000162	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTEN—kidney cancer	1.01e-06	0.000161	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—POMC—kidney cancer	1e-06	0.000161	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—POMC—kidney cancer	9.96e-07	0.00016	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCB1—kidney cancer	9.57e-07	0.000154	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.38e-07	0.000151	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—kidney cancer	9.29e-07	0.000149	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1A1—kidney cancer	8.81e-07	0.000141	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—kidney cancer	8.71e-07	0.00014	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—POMC—kidney cancer	8.51e-07	0.000137	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—kidney cancer	8.01e-07	0.000129	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—kidney cancer	7.94e-07	0.000128	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTEN—kidney cancer	7.6e-07	0.000122	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—kidney cancer	7.09e-07	0.000114	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTEN—kidney cancer	6.99e-07	0.000112	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTEN—kidney cancer	6.93e-07	0.000111	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—kidney cancer	6.79e-07	0.000109	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—POMC—kidney cancer	6.57e-07	0.000105	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTEN—kidney cancer	5.92e-07	9.51e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—kidney cancer	5.36e-07	8.61e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—kidney cancer	5.24e-07	8.41e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—kidney cancer	4.93e-07	7.92e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—kidney cancer	4.89e-07	7.85e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTEN—kidney cancer	4.57e-07	7.34e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—kidney cancer	4.18e-07	6.71e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.22e-07	5.18e-05	CbGpPWpGaD
